Chase Investment Counsel Corp. »

Catalyst Pharmaceutical Partners shares owned by Chase Investment Counsel Corp.

Quarter-by-quarter ownership of Catalyst Pharmaceutical Partners (CPRX) shares owned by Chase Investment Counsel Corp. from 13F filings

Historical chart of Chase Investment Counsel Corp. investment in Catalyst Pharmaceutical Partners

Tip: Access up to 7 years of quarterly data

All positions including Catalyst Pharmaceutical Partners held by Chase Investment Counsel Corp. consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Catalyst Pharmaceutical Partners by Chase Investment Counsel Corp.

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.2M 60k 19.70
2025-06-30 $1.2M 54k 21.69
2025-03-31 $1.3M 54k 24.24
2024-12-31 $1.1M 54k 20.85

More positions owned by Chase Investment Counsel Corp.

NVIDIA Corporation (NVDA)
Celestica (CLS)
Alphabet Cap Stk Cl A (GOOGL)
Meta Platforms Cl A (META)
Broadcom (AVGO)
Vertiv Holdings Com Cl A (VRT)
Bank of New York Mellon Corporation (BK)
Goldman Sachs (GS)
eBay (EBAY)
Agnico (AEM)
Abbvie (ABBV)
Howmet Aerospace (HWM)
Amazon (AMZN)
National Fuel Gas (NFG)
Capital One Financial (COF)

View all positions for Chase Investment Counsel Corp.

Top funds holding Catalyst Pharmaceutical Partners

BlackRock
Vanguard Group
State Street Corporation
Deerfield Management Company
Renaissance Technologies
Fundsmith
Morgan Stanley
Geode Capital Management
American Century Companies
Dimensional Fund Advisors
Royce & Associates
Millennium Management
Charles Schwab Investment Management
Arrowstreet Capital, Limited Partnership
Robeco Investment Management

View all funds holding Catalyst Pharmaceutical Partners